- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03185715
Oocyte Recipient's Decision in the Number of Embryos to be Transferred
June 12, 2017 updated by: Elisabet Clua Obrado, Institut Universitari Dexeus
Single or Double Embryo Transfer? Decision-making Process in Patients Participating in an Oocyte Donation Program
Multiple pregnancies are considered an ART complication.
The only effective way to reduce its incidence is to transfer a single embryo.
Nonetheless, there is some reluctance among the patients to accept this strategy.
In IVF/ICSI programs, it has been demonstrated that, after receiving the information about the similar cumulative live birth rate after single embryo transfer (SET) and double embryo transfer (DET) and the obstetric and perinatal risks of multiple pregnancy, a significant number of patients opt for SET.
Up to date, no comparable studies have been published in oocyte recipients.
The aim of this study is to evaluate if the information given to the patients influence their preference on the number of embryos to be transferred.
It also seeks to identify factors which determine the initial preference and factors which can explain a hypothetic change in this preference.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients under their first oocyte or embryo donation cycle.
- Sufficient knowledge of Spanish to fill out questionnaires.
Exclusion Criteria:
- Patients with a medical indication for single embryo transfer (e.g. Turner syndrome, uterine surgeries, cardiovascular risk).
- Having had previous oocyte or embryo donation cycles.
- Insufficient knowledge of Spanish.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Counseling policy embryo transfer
All recipients completed a validated self-report questionnaire on the preference on the number of embryos to be transferred and the relevance for the decision-making process attributed to certain factors.
The questionnaire also included questions on sociodemographic characteristics, medical-reproductive background and cycle's results and risks perception.
All recipients received oral and written counselling.
After counselling, during the treatment, the recipients completed a second questionnaire in order to check if their decision had changed.
|
Recipients were informed about success rates of SET and DET and also about the possible risks of DET.
All the information was given orally and written.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Preference change on the number of embryos to be transferred
Time Frame: Up to 3 months
|
Preference was evaluated at the first consultation and after counselling using a self-report questionnaire.
|
Up to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Factors which determine the initial preference on the number of embryos to be transferred
Time Frame: At the first consultation
|
Factor's weight is analysed using a self-report questionnaire.
Each factor is scored 1-10 according its relevance.
|
At the first consultation
|
|
Factors which can explain a change in the preference on the number of embryos to be transferred
Time Frame: Up to 3 months
|
Each factor is scored 1-10 according its relevance.
Score before counselling and score after counselling were compared.
|
Up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Elisabet Clua, PhD, Institut Universitari Dexeus
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Land JA, Evers JL. Risks and complications in assisted reproduction techniques: Report of an ESHRE consensus meeting. Hum Reprod. 2003 Feb;18(2):455-7. doi: 10.1093/humrep/deg081.
- van Peperstraten AM, Nelen WL, Hermens RP, Jansen L, Scheenjes E, Braat DD, Grol RP, Kremer JA. Why don't we perform elective single embryo transfer? A qualitative study among IVF patients and professionals. Hum Reprod. 2008 Sep;23(9):2036-42. doi: 10.1093/humrep/den156. Epub 2008 Jun 18.
- Ryan GL, Sparks AE, Sipe CS, Syrop CH, Dokras A, Van Voorhis BJ. A mandatory single blastocyst transfer policy with educational campaign in a United States IVF program reduces multiple gestation rates without sacrificing pregnancy rates. Fertil Steril. 2007 Aug;88(2):354-60. doi: 10.1016/j.fertnstert.2007.03.001. Epub 2007 May 9.
- Hope N, Rombauts L. Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study. Fertil Steril. 2010 Jul;94(2):489-95. doi: 10.1016/j.fertnstert.2009.03.080. Epub 2009 May 13.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2014
Primary Completion (Actual)
May 1, 2017
Study Completion (Actual)
May 1, 2017
Study Registration Dates
First Submitted
May 19, 2017
First Submitted That Met QC Criteria
June 12, 2017
First Posted (Actual)
June 14, 2017
Study Record Updates
Last Update Posted (Actual)
June 14, 2017
Last Update Submitted That Met QC Criteria
June 12, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMD-2014-121
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility, Female
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Newlife Fertility CentreRecruitingInfertility | Infertility,Female | Infertility Unexplained | Infertility of Uterine Origin | Infertility; Female, NonimplantationCanada
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Cairo UniversityCompleted
-
Navy General Hospital, BeijingUnknownFemale Infertility Due to Nonimplantation of OvumChina
-
BEYOND GENOMiX SA, AG, LtdPraxis für Akupunktur und Chinesische Arzneimittel; Fertisuisse Ltd, SA, AGRecruitingInfertility Unexplained | Infertility (IVF Patients) | Idiopathic Infertility | Infertility Female | Infertility Assisted Reproductive TechnologySwitzerland
-
Sapientiae InstituteTerminated
Clinical Trials on Oral and written counselling
-
Fundació Privada EuginCompleted
-
Copenhagen Trial Unit, Center for Clinical Intervention...Hvidovre University Hospital; Section for Health Services Research, Department...Completed
-
Valduce HospitalCompleted
-
Peking UniversityRecruitingCPTSD, Compelx Post-traumatic Stress DisorderChina
-
Saglik Bilimleri UniversitesiCompletedBreast Cancer | Educational Problems | Bypass ComplicationTurkey
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
Bahçeşehir UniversityTerminated
-
Hillel Yaffe Medical CenterUnknownNewborn MorbidityIsrael
-
Umeå UniversityVastra Gotaland Region; Region Östergötland; Region Stockholm; Region Örebro County and other collaboratorsCompletedDiabetes Mellitus, Type 2Sweden
-
Massachusetts General HospitalCompleted